Loss of regulation of complement C5 activation in HIV associated Preeclampsia
Preprint
Abstract
Objective: Maternal mortality remains a global health concern in developing countries that are also affected by HIV infection. Complement components are anaphylatoxin that mediate several growth factors necessary during pregnancy. An extensive stimulation of the complement system contributes to the pathogenesis of preeclampsia; hence its inhibition facilitates a successful pregnancy. The study evaluated the expression of complement components C2 and C5a in HIV and the association with preeclampsia. Materials and Methods: Serum samples were collected from 76 pregnant women of which 38 were preeclamptic and 38 normotensive pregnant. The participants were further stratified according to HIV infection status. Bio-Plex multiplex immunoassay method was used to quantify serum concentration of C5a and C2 complement components. Results: The C2 complement concentration was not significantly different between preeclamptic and normotensive pregnant women, irrespective of HIV status as well as pregnancy type. However, based on preeclamptic vs normotensive pregnancy type, the expression of C5a was significantly different ( p = 0.05). The C5a levels were downregulated in preeclampsia compared to normotensive women, irrespective of HIV status. Both C2 and C5a concentrations did not differ across all study groups. Conclusion: This novel study reports a loss of regulation of complement activation shown by the downregulation of C5a in preeclamptic compared to normotensive pregnant women, regardless of HIV status. Complement dysregulation affects the host innate defence, and as a consequence, intensifies placental and fetal injury. Moreover, HIV status did not influence the expression of both C5a and C2, irrespective of pregnancy type, this may be attributed to Highly Active Antiretroviral Therapy.Keywords
This publication has 52 references indexed in Scilit:
- Maternal imbalance between pro-angiogenic and anti-angiogenic factors in HIV-infected women with pre-eclampsia : cardiovascular topicsCardioVascular Journal of Africa, 2013
- HSV Neutralization by the Microbicidal Candidate C5APLOS ONE, 2011
- Into the wild: The soybean genome meets its undomesticated relativeProceedings of the National Academy of Sciences, 2010
- The complement systemCell and tissue research, 2010
- Dysregulated Complement Activation as a Common Pathway of Injury in Preeclampsia and Other Pregnancy ComplicationsPlacenta, 2010
- The good and evil of complement activation in HIV-1 infectionCellular & Molecular Immunology, 2010
- The role of the anaphylatoxins in health and diseaseMolecular Immunology, 2009
- C5a Enhances Dysregulated Inflammatory and Angiogenic Responses to Malaria In Vitro: Potential Implications for Placental MalariaPLOS ONE, 2009
- A virocidal amphipathic α-helical peptide that inhibits hepatitis C virus infection in vitroProceedings of the National Academy of Sciences, 2008
- Complement Activation Pathways: A Bridge between Innate and Adaptive Immune Responses in AsthmaProceedings of the American Thoracic Society, 2007